AI-ACCELERATED DRUG DISCOVERY
Available from Reaxense
This protein is integrated into the Receptor.AI ecosystem as a prospective target with high therapeutic potential. We performed a comprehensive characterization of PR domain zinc finger protein 8 including:
1. LLM-powered literature research
Our custom-tailored LLM extracted and formalized all relevant information about the protein from a large set of structured and unstructured data sources and stored it in the form of a Knowledge Graph. This comprehensive analysis allowed us to gain insight into PR domain zinc finger protein 8 therapeutic significance, existing small molecule ligands, relevant off-targets, and protein-protein interactions.
Fig. 1. Preliminary target research workflow
2. AI-Driven Conformational Ensemble Generation
Starting from the initial protein structure, we employed advanced AI algorithms to predict alternative functional states of PR domain zinc finger protein 8, including large-scale conformational changes along "soft" collective coordinates. Through molecular simulations with AI-enhanced sampling and trajectory clustering, we explored the broad conformational space of the protein and identified its representative structures. Utilizing diffusion-based AI models and active learning AutoML, we generated a statistically robust ensemble of equilibrium protein conformations that capture the receptor's full dynamic behavior, providing a robust foundation for accurate structure-based drug design.
Fig. 2. AI-powered molecular dynamics simulations workflow
3. Binding pockets identification and characterization
We employed the AI-based pocket prediction module to discover orthosteric, allosteric, hidden, and cryptic binding pockets on the protein’s surface. Our technique integrates the LLM-driven literature search and structure-aware ensemble-based pocket detection algorithm that utilizes previously established protein dynamics. Tentative pockets are then subject to AI scoring and ranking with simultaneous detection of false positives. In the final step, the AI model assesses the druggability of each pocket enabling a comprehensive selection of the most promising pockets for further targeting.
Fig. 3. AI-based binding pocket detection workflow
4. AI-Powered Virtual Screening
Our ecosystem is equipped to perform AI-driven virtual screening on PR domain zinc finger protein 8. With access to a vast chemical space and cutting-edge AI docking algorithms, we can rapidly and reliably predict the most promising, novel, diverse, potent, and safe small molecule ligands of PR domain zinc finger protein 8. This approach allows us to achieve an excellent hit rate and to identify compounds ready for advanced lead discovery and optimization.
Fig. 4. The screening workflow of Receptor.AI
Receptor.AI, in partnership with Reaxense, developed a next-generation technology for on-demand focused library design to enable extensive target exploration.
The focused library for PR domain zinc finger protein 8 includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
PR domain zinc finger protein 8
partner:
Reaxense
upacc:
Q9NQV8
UPID:
PRDM8_HUMAN
Alternative names:
PR domain-containing protein 8
Alternative UPACC:
Q9NQV8; A8K7X2; Q6IQ36
Background:
PR domain zinc finger protein 8, alternatively known as PR domain-containing protein 8, plays a crucial role in various biological processes. It acts as a probable histone methyltransferase, targeting 'Lys-9' of histone H3, and is involved in transcriptional repression of steroidogenesis marker genes such as CYP17A1 and LHCGR. Additionally, it forms a complex with BHLHE22 to control genes essential for neural development and neuronal differentiation. In the retina, it is vital for the survival of rod bipolar and type 2 OFF-cone bipolar cells.
Therapeutic significance:
The protein's association with Epilepsy, progressive myoclonic 10, a disorder characterized by a spectrum of symptoms including myoclonus, ataxia, and cognitive decline, underscores its therapeutic significance. Understanding the role of PR domain zinc finger protein 8 could open doors to potential therapeutic strategies for this and related neurological conditions.
